BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 23696568)

  • 1. Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors.
    Anagnostopoulou V; Pediaditakis I; Alkahtani S; Alarifi SA; Schmidt EM; Lang F; Gravanis A; Charalampopoulos I; Stournaras C
    Endocrinology; 2013 Jul; 154(7):2446-56. PubMed ID: 23696568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis.
    Lazaridis I; Charalampopoulos I; Alexaki VI; Avlonitis N; Pediaditakis I; Efstathopoulos P; Calogeropoulou T; Castanas E; Gravanis A
    PLoS Biol; 2011 Apr; 9(4):e1001051. PubMed ID: 21541365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor.
    Hughes AL; Messineo-Jones D; Lad SP; Neet KE
    J Neurosci Res; 2001 Jan; 63(1):10-9. PubMed ID: 11169609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth arrest of PC12 cells by nerve growth factor is dependent on the phosphatidylinositol 3-kinase/Akt pathway via p75 neurotrophin receptor.
    Ito H; Nomoto H; Furukawa S
    J Neurosci Res; 2003 Apr; 72(2):211-7. PubMed ID: 12671996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of GnRH analogs on the expression of TrkA and p75 neurotrophin receptors in primary cell cultures from human prostate adenocarcinoma.
    Sánchez C; Clementi M; Benitez D; Contreras H; Huidobro C; Castellón E
    Prostate; 2005 Nov; 65(3):195-202. PubMed ID: 15948150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nerve growth factor exerts differential effects on the growth of human pancreatic cancer cells.
    Zhu ZW; Friess H; Wang L; Bogardus T; Korc M; Kleeff J; Büchler MW
    Clin Cancer Res; 2001 Jan; 7(1):105-12. PubMed ID: 11205897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve growth factor-induced protein kinase C stimulation contributes to TrkA-dependent inhibition of p75 neurotrophin receptor sphingolipid signaling.
    Plo I; Bono F; Bezombes C; Alam A; Bruno A; Laurent G
    J Neurosci Res; 2004 Aug; 77(4):465-74. PubMed ID: 15264216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel functional interactions between Trk kinase and p75 neurotrophin receptor in neuroblastoma cells.
    Lachyankar MB; Condon PJ; Daou MC; De AK; Levine JB; Obermeier A; Ross AH
    J Neurosci Res; 2003 Jan; 71(2):157-72. PubMed ID: 12503079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational basis for Trk inhibition therapy for prostate cancer.
    Weeraratna AT; Arnold JT; George DJ; DeMarzo A; Isaacs JT
    Prostate; 2000 Oct; 45(2):140-8. PubMed ID: 11027413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro.
    Pierucci D; Cicconi S; Bonini P; Ferrelli F; Pastore D; Matteucci C; Marselli L; Marchetti P; Ris F; Halban P; Oberholzer J; Federici M; Cozzolino F; Lauro R; Borboni P; Marlier LN
    Diabetologia; 2001 Oct; 44(10):1281-95. PubMed ID: 11692177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurosteroids and microneurotrophins signal through NGF receptors to induce prosurvival signaling in neuronal cells.
    Gravanis A; Calogeropoulou T; Panoutsakopoulou V; Thermos K; Neophytou C; Charalampopoulos I
    Sci Signal; 2012 Oct; 5(246):pt8. PubMed ID: 23074265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer.
    Zhang Y; Dang C; Ma Q; Shimahara Y
    Oncol Rep; 2005 Jul; 14(1):161-71. PubMed ID: 15944784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of low-affinity p75 receptor in nerve growth factor-inducible growth arrest of PC12 cells.
    Ito H; Nomoto H; Furukawa S
    J Neurosci Res; 2002 Sep; 69(5):653-61. PubMed ID: 12210831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative effects of DHEA vs. testosterone, dihydrotestosterone, and estradiol on proliferation and gene expression in human LNCaP prostate cancer cells.
    Arnold JT; Le H; McFann KK; Blackman MR
    Am J Physiol Endocrinol Metab; 2005 Mar; 288(3):E573-84. PubMed ID: 15536203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type I interferons up-regulate the expression and signalling of p75 NTR/TrkA receptor complex in differentiated human SH-SY5Y neuroblastoma cells.
    Dedoni S; Olianas MC; Ingianni A; Onali P
    Neuropharmacology; 2014 Apr; 79():321-34. PubMed ID: 24333329
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p75 neurotrophin receptor is required for constitutive and NGF-induced survival signalling in PC12 cells and rat hippocampal neurones.
    Bui NT; König HG; Culmsee C; Bauerbach E; Poppe M; Krieglstein J; Prehn JH
    J Neurochem; 2002 May; 81(3):594-605. PubMed ID: 12065668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NGF and ProNGF: Regulation of neuronal and neoplastic responses through receptor signaling.
    Bradshaw RA; Pundavela J; Biarc J; Chalkley RJ; Burlingame AL; Hondermarck H
    Adv Biol Regul; 2015 May; 58():16-27. PubMed ID: 25491371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dehydroepiandrosterone induces a neuroendocrine phenotype in nerve growth factor-stimulated chromaffin pheochromocytoma PC12 cells.
    Ziegler CG; Sicard F; Lattke P; Bornstein SR; Ehrhart-Bornstein M; Krug AW
    Endocrinology; 2008 Jan; 149(1):320-8. PubMed ID: 17884937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TrkA as a life and death receptor: receptor dose as a mediator of function.
    Yan C; Liang Y; Nylander KD; Schor NF
    Cancer Res; 2002 Sep; 62(17):4867-75. PubMed ID: 12208732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dehydroepiandrosterone: an ancestral ligand of neurotrophin receptors.
    Pediaditakis I; Iliopoulos I; Theologidis I; Delivanoglou N; Margioris AN; Charalampopoulos I; Gravanis A
    Endocrinology; 2015 Jan; 156(1):16-23. PubMed ID: 25330101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.